🇺🇸 FDA
Patent

US 11497793

Compositions and methods for treating glioblastoma

granted A61KA61K31/495A61K38/06

Quick answer

US patent 11497793 (Compositions and methods for treating glioblastoma) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/495, A61K38/06, A61K38/08, A61K38/177